Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Bovine Mastitis Market

ID: MRFR/HC/35110-HCR
128 Pages
Satyendra Maurya
Last Updated: April 24, 2026

Bovine Mastitis Market Research Report: Size, Share, Trend Analysis By Product Type (Antibiotics, Non-Steroidal Anti-Inflammatory Drugs, Other Veterinary Medicinal Products), By Administration Route (Intramammary, Oral, Injection), By Cattle Type (Dairy Cattle, Beef Cattle), By Distribution Channel (Veterinary Clinics, Online Pharmacies, Agricultural Stores) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Bovine Mastitis Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Product Type (USD Billion) | |
      1. 4.1.1 Antibiotics | |
      2. 4.1.2 Non-Steroidal Anti-Inflammatory Drugs | |
      3. 4.1.3 Other Veterinary Medicinal Products |
    2. 4.2 Healthcare, BY Administration Route (USD Billion) | |
      1. 4.2.1 Intramammary | |
      2. 4.2.2 Oral | |
      3. 4.2.3 Injection |
    3. 4.3 Healthcare, BY Cattle Type (USD Billion) | |
      1. 4.3.1 Dairy Cattle | |
      2. 4.3.2 Beef Cattle |
    4. 4.4 Healthcare, BY Distribution Channel (USD Billion) | |
      1. 4.4.1 Veterinary Clinics | |
      2. 4.4.2 Online Pharmacies | |
      3. 4.4.3 Agricultural Stores |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Zoetis (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Merck Animal Health (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Boehringer Ingelheim (DE) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Elanco Animal Health (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Cegelec (FR) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Vetoquinol (FR) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Huvepharma (BG) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Dechra Pharmaceuticals (GB) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Phibro Animal Health (US) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY PRODUCT TYPE |
    7. 6.4 US MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    8. 6.5 US MARKET ANALYSIS BY CATTLE TYPE |
    9. 6.6 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    10. 6.7 CANADA MARKET ANALYSIS BY PRODUCT TYPE |
    11. 6.8 CANADA MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    12. 6.9 CANADA MARKET ANALYSIS BY CATTLE TYPE |
    13. 6.10 CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY PRODUCT TYPE |
    16. 6.13 GERMANY MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    17. 6.14 GERMANY MARKET ANALYSIS BY CATTLE TYPE |
    18. 6.15 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    19. 6.16 UK MARKET ANALYSIS BY PRODUCT TYPE |
    20. 6.17 UK MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    21. 6.18 UK MARKET ANALYSIS BY CATTLE TYPE |
    22. 6.19 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    23. 6.20 FRANCE MARKET ANALYSIS BY PRODUCT TYPE |
    24. 6.21 FRANCE MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    25. 6.22 FRANCE MARKET ANALYSIS BY CATTLE TYPE |
    26. 6.23 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    27. 6.24 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE |
    28. 6.25 RUSSIA MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    29. 6.26 RUSSIA MARKET ANALYSIS BY CATTLE TYPE |
    30. 6.27 RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    31. 6.28 ITALY MARKET ANALYSIS BY PRODUCT TYPE |
    32. 6.29 ITALY MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    33. 6.30 ITALY MARKET ANALYSIS BY CATTLE TYPE |
    34. 6.31 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    35. 6.32 SPAIN MARKET ANALYSIS BY PRODUCT TYPE |
    36. 6.33 SPAIN MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    37. 6.34 SPAIN MARKET ANALYSIS BY CATTLE TYPE |
    38. 6.35 SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY CATTLE TYPE |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY PRODUCT TYPE |
    45. 6.42 CHINA MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    46. 6.43 CHINA MARKET ANALYSIS BY CATTLE TYPE |
    47. 6.44 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    48. 6.45 INDIA MARKET ANALYSIS BY PRODUCT TYPE |
    49. 6.46 INDIA MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    50. 6.47 INDIA MARKET ANALYSIS BY CATTLE TYPE |
    51. 6.48 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    52. 6.49 JAPAN MARKET ANALYSIS BY PRODUCT TYPE |
    53. 6.50 JAPAN MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    54. 6.51 JAPAN MARKET ANALYSIS BY CATTLE TYPE |
    55. 6.52 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY CATTLE TYPE |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY CATTLE TYPE |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    64. 6.61 THAILAND MARKET ANALYSIS BY PRODUCT TYPE |
    65. 6.62 THAILAND MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    66. 6.63 THAILAND MARKET ANALYSIS BY CATTLE TYPE |
    67. 6.64 THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    68. 6.65 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE |
    69. 6.66 INDONESIA MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    70. 6.67 INDONESIA MARKET ANALYSIS BY CATTLE TYPE |
    71. 6.68 INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY CATTLE TYPE |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE |
    78. 6.75 BRAZIL MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    79. 6.76 BRAZIL MARKET ANALYSIS BY CATTLE TYPE |
    80. 6.77 BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    81. 6.78 MEXICO MARKET ANALYSIS BY PRODUCT TYPE |
    82. 6.79 MEXICO MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    83. 6.80 MEXICO MARKET ANALYSIS BY CATTLE TYPE |
    84. 6.81 MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY CATTLE TYPE |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY CATTLE TYPE |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY CATTLE TYPE |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY CATTLE TYPE |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY ADMINISTRATION ROUTE |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY CATTLE TYPE |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY ADMINISTRATION ROUTE, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY ADMINISTRATION ROUTE, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY CATTLE TYPE, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY CATTLE TYPE, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY CATTLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Product Type (USD Billion, 2025-2035)

  • Antibiotics
  • Non-Steroidal Anti-Inflammatory Drugs
  • Other Veterinary Medicinal Products

Healthcare By Administration Route (USD Billion, 2025-2035)

  • Intramammary
  • Oral
  • Injection

Healthcare By Cattle Type (USD Billion, 2025-2035)

  • Dairy Cattle
  • Beef Cattle

Healthcare By Distribution Channel (USD Billion, 2025-2035)

  • Veterinary Clinics
  • Online Pharmacies
  • Agricultural Stores

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions